Could a common antibiotic save thousands of Children's lives?
NCT ID NCT04235816
First seen Apr 04, 2026 · Last updated Apr 25, 2026 · Updated 3 times
Summary
This study tests whether adding an antibiotic (azithromycin) to standard malaria prevention given during routine childhood vaccines can lower the number of children who die before age 5. About 20,560 infants in Sierra Leone will receive either the usual malaria medicine or that medicine plus azithromycin at their vaccination visits. The goal is to find a simple, low-cost way to reduce deaths from infections like malaria, pneumonia, and diarrhea.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILD MORTALITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
College of Medicine and Allied Health Sciences
Freetown, Sierra Leone
Conditions
Explore the condition pages connected to this study.